User profiles for Kerstin Klaser

Kerstin Klaser

Research Scientist, Graphcore
Verified email at graphcore.ai
Cited by 6206

[HTML][HTML] Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2

…, M Antonelli, B Murray, K Kläser… - The Lancet Child & …, 2021 - thelancet.com
Background In children, SARS-CoV-2 infection is usually asymptomatic or causes a mild
illness of short duration. Persistent illness has been reported; however, its prevalence and …

[HTML][HTML] Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study

C Menni, K Klaser, A May, L Polidori… - The Lancet Infectious …, 2021 - thelancet.com
Background The Pfizer-BioNTech (BNT162b2) and the Oxford-AstraZeneca (ChAdOx1
nCoV-19) COVID-19 vaccines have shown excellent safety and efficacy in phase 3 trials. We …

[HTML][HTML] Attributes and predictors of long COVID

…, RS Penfold, RC Bowyer, JC Pujol, K Klaser… - Nature medicine, 2021 - nature.com
Reports of long-lasting coronavirus disease 2019 (COVID-19) symptoms, the so-called ‘long
COVID’, are rising but little is known about prevalence, risk factors or whether it is possible …

[HTML][HTML] Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based …

…, S Berry, LS Canas, MS Graham, K Klaser… - The Lancet Infectious …, 2022 - thelancet.com
Background COVID-19 vaccines show excellent efficacy in clinical trials and effectiveness
in real-world data, but some people still become infected with SARS-CoV-2 after vaccination. …

[HTML][HTML] Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study

…, M Antonelli, B Murray, T Varsavsky, K Kläser… - The Lancet Public …, 2021 - thelancet.com
Background The SARS-CoV-2 variant B.1.1.7 was first identified in December, 2020, in
England. We aimed to investigate whether increases in the proportion of infections with this …

PET/MRI attenuation estimation in the lung: a review of past, present, and potential techniques

J Lillington, L Brusaferri, K Kläser, K Shmueli… - Medical …, 2020 - Wiley Online Library
Positron emission tomography/magnetic resonance imaging (PET/MRI) potentially offers
several advantages over positron emission tomography/computed tomography (PET/CT), for …

[HTML][HTML] Modest effects of dietary supplements during the COVID-19 pandemic: insights from 445 850 users of the COVID-19 Symptom Study app

P Louca, B Murray, K Klaser, MS Graham… - … nutrition, prevention & …, 2021 - ncbi.nlm.nih.gov
Objectives Dietary supplements may ameliorate SARS-CoV-2 infection, although scientific
evidence to support such a role is lacking. We investigated whether users of the COVID-19 …

[HTML][HTML] Early detection of COVID-19 in the UK using self-reported symptoms: a large-scale, prospective, epidemiological surveillance study

…, B Murray, E Molteni, MS Graham, K Klaser… - The Lancet Digital …, 2021 - thelancet.com
Background Self-reported symptoms during the COVID-19 pandemic have been used to train
artificial intelligence models to identify possible infection foci. To date, these models have …

Anxiety and depression symptoms after COVID-19 infection: results from the COVID Symptom Study app

K Klaser, EJ Thompson, LH Nguyen… - Journal of Neurology …, 2021 - jnnp.bmj.com
Background Mental health issues have been reported after SARS-CoV-2 infection. However,
comparison to prevalence in uninfected individuals and contribution from common risk …

[HTML][HTML] COVID-19 due to the B. 1.617. 2 (Delta) variant compared to B. 1.1. 7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study

K Kläser, E Molteni, M Graham, LS Canas… - Scientific reports, 2022 - nature.com
The Delta (B.1.617.2) variant was the predominant UK circulating SARS-CoV-2 strain
between May and December 2021. How Delta infection compares with previous variants is …